Beruflich Dokumente
Kultur Dokumente
n e w e ng l a n d j o u r na l
of
m e dic i n e
468
Differ en t i a l Di agnosis
Dr. Linden T. Hu: A 28-year-old pregnant woman
presented with an acute onset of fevers, myalgias,
headache, and neck stiffness during the summer
in Massachusetts. Summer fevers are a common
occurrence in many parts of the United States
(Table2). Infection-related summer fevers are not
commonly caused by the adenoviruses, rhinoviruses, and influenza that dominate during the
winter months in temperate areas; instead, enteroviruses (e.g., coxsackievirus) and infections resulting from outdoor exposure to environmental or
zoonotic reservoirs of disease are prevalent. In
Massachusetts, many of these agents are transmitted by mosquito or tick vectors.
Although this patient did not identify a specific tick or mosquito bite, these are recognized
in a minority of cases.1,2 She did have multiple
opportunities for exposure to these agents, given
her frequent travel to coastal Massachusetts and
her participation in outdoor activities. Differentiating between potential causes of summer fevers is often difficult because of the nonspecific
nature of the symptoms, particularly during the
early stages of infection. However, certain features
of this patients presentation including headache, rash, thrombocytopenia, and hepatitis
469
The
n e w e ng l a n d j o u r na l
of
m e dic i n e
Variable
On Admission,
This Hospital
4th Day,
This Hospital
Hematocrit (%)
36.046.0 (women)
34.1
30.4
Hemoglobin (g/dl)
12.016.0 (women)
12.1
11.0
450011,000
5900
6800
Neutrophils
4070
90.0
62.0
Lymphocytes
2244
6.1
29.0
Monocytes
411
3.0
7.0
Eosinophils
08
2.0
mm3)
Basophils
03
0.2
150,000400,000
81,000
122,000
Sodium (mmol/liter)
135145
134
Potassium (mmol/liter)
3.44.8
3.7
Chloride (mmol/liter)
100108
99
23.031.9
22.8
315
12
825
Total
0.01.0
0.5
1.3
Direct
0.00.4
0.2
0.8
932
297
383
733
329
468
110210
283
Bilirubin (mg/dl)
* To convert the values for urea nitrogen to millimoles per liter, multiply by 0.357. To convert the values for bilirubin to
micromoles per liter, multiply by 17.1.
Reference values are affected by many variables, including the patient population and the laboratory methods used. The
ranges used at Massachusetts General Hospital are for adults who are not pregnant and do not have medical condi
tions that could affect the results. They may therefore not be appropriate for all patients.
may offer clues to the most likely diagnoses reported a mild headache, we cannot rule out these
(Table3).
diagnoses on the basis of the severity of this symptom, especially early during the course of the
Headache
illness.
Headache is a common, nonspecific finding asMeningitis with associated neck stiffness can
sociated with many febrile illnesses. Infections be consistent with infections such as Lyme disease,
with pathogens that are able to cross the blood human granulocytic anaplasmosis, Rocky Mounbrain barrier and directly infect cells of the cen- tain spotted fever, and enterovirus, but it affects
tral nervous system are typically manifested by a minority of patients and headaches can occur
severe headaches as a prominent early feature. in the absence of meningitis. Deer tick virus and
From our list of infections that cause summer eastern equine encephalitis typically cause severe
fever, Lyme disease, human granulocytic ana- meningoencephalitis and are not compatible with
plasmosis, Rocky Mountain spotted fever, lepto- this patients presentation.
spirosis, eastern equine encephalitis, West Nile
Borrelia miyamotoi, which was first identified
virus, deer tick virus, tularemia, and enterovirus all as a human pathogen in 2011, is now recognized
commonly cause headache. Although this patient as the fifth agent of human disease to be trans-
470
mitted by the Ixodes scapularis tick in the northeastern United States.3 The organism is most closely
related to the borrelia species that causes relapsing fever. A limited amount of information about
the symptomatic disease associated with B. miyamotoi is currently available, but it may cause a
syndrome that is similar to relapsing fever, with
prominent headaches and meningitis (reported
in an immunocompromised patient), fevers, myalgias, and fatigue.4-6
Rash
Powassan virus
Hepatitis
At the time of admission to this hospital, this patient had clinically significant elevations in hepatic
aminotransferase levels that were indicative of
mild-to-moderate hepatitis. This is a common
finding in patients with human granulocytic anaplasmosis11 and has also been reported in patients
with Lyme disease, although this patients hepa-
471
The
n e w e ng l a n d j o u r na l
of
m e dic i n e
Headache
Rash
Thrombocytopenia
Hepatitis
Lyme disease
Common
Very common
Uncommon
Somewhat common
Common
Uncommon
Common
Common
Somewhat common
Uncommon
Uncommon
Uncommon
Common
Uncertain
Common
Common
Babesiosis
Borrelia miyamotoi infection
Deer tick virus
Very common
Uncommon
Uncommon
Uncommon
Very common
Very common
Common
Somewhat common
Somewhat common
Tularemia
Somewhat common
Common
Common
Somewhat common
Very common
Uncommon
Uncommon
Common
Common
Somewhat common
Uncommon
Very common
Uncommon
Uncommon
Uncommon
Enterovirus
Very common
Somewhat common
Uncommon
Somewhat common
Leptospirosis
Very common
Somewhat common
Common
Common
472
Cl inic a l Di agnosis
Anaplasmosis or Borrelia miyamotoi infection.
for the IgG antibodies, findings that are consistent with recent B. miyamotoi infection. The glpQ
antigen is present in borreliae that cause relapsing fever (including B. miyamotoi) but is absent in
borreliae that cause Lyme disease; thus, ELISA for
antibodies to the glpQ antigen helps to distinguish between these categories of borrelia infection.18 In contrast, reactivity to serologic assays
for Lyme disease that were designed for use in
Europe3 and North America13 has been reported
in patients with B. miyamotoi infection.
In this patient, ELISA was negative for B. burgdorferi on the day after admission to this hospital, but 5 days later, a repeat test was positive. A
supplemental Western immunoblot assay was positive for IgM antibodies to B. burgdorferi, with all
three relevant IgM bands detected (p23, p39, and
p41), and was negative for IgG antibodies, with
no bands detected. Although the serologic findings for B. burgdorferi could represent cross-reactivity from B. miyamotoi infection, they are also
consistent with early Lyme borreliosis. Thus, the
microbiologic diagnosis in this case was B. miyamotoi infection with a possible B. burgdorferi coinfection.
Dr. Rosenberg: Dr. Tsibris, would you tell us
how you treated this patient?
Dr. Tsibris: The patient had marked improvement during the first 24 hours of receiving antibiotic therapy, and a lumbar puncture was deferred. The high probability of anaplasmosis led
us to recommend an empirical 7-day course of
oral rifampin, which was complicated by elevated
hepatic aminotransferase levels that were eight
to nine times as high as the upper limit of the
normal range.
The ideal treatment for B. miyamotoi infection
and the risk of transplacental fetal infection are
unknown. We elected to treat the patient with
intravenous ceftriaxone for 4 weeks. Persistent
elevation of bile-salt levels resulted in a diagnosis of intrahepatic cholestasis of pregnancy that
improved with the administration of ursodiol.
Labor was induced at 37 weeks of gestation, and
the patient had a vaginal delivery of a boy with
normal Apgar scores. At his 1-month and 4-month
checkups, the infant and his mother were noted
to be doing well.
Dr. Rosenberg: Since this is a relatively newly
recognized infection, can you give us guidance on
when it is appropriate to test for B. miyamotoi?
473
The
n e w e ng l a n d j o u r na l
474
of
m e dic i n e
Fina l Di agnosis
Borrelia miyamotoi infection and possible Borrelia
burgdorferi infection.
Presented at Medical Grand Rounds.
Dr. Hu reports receiving consulting fees from Abzyme and
grant support to his institution from FoodSource Lure; Dr. Tsibris, consulting and editing fees from DynaMed/EBSCO; and Dr.
Branda, consulting fees from AdvanDx and grant support to his
institution from bioMerieux, Immunetics, Alere, and DiaSorin.
No other potential conflict of interest relevant to this article was
reported.
Disclosure forms provided by the authors are available with
the full text of this article at NEJM.org.
Lantern Slides Updated: Complete PowerPoint Slide Sets from the Clinicopathological Conferences
Any reader of the Journal who uses the Case Records of the Massachusetts General Hospital as a teaching exercise or reference
material is now eligible to receive a complete set of PowerPoint slides, including digital images, with identifying legends,
shown at the live Clinicopathological Conference (CPC) that is the basis of the Case Record. This slide set contains all of the
images from the CPC, not only those published in the Journal. Radiographic, neurologic, and cardiac studies, gross specimens,
and photomicrographs, as well as unpublished text slides, tables, and diagrams, are included. Every year 40 sets are produced,
averaging 50-60 slides per set. Each set is supplied on a compact disc and is mailed to coincide with the publication of the
Case Record.
The cost of an annual subscription is $600, or individual sets may be purchased for $50 each. Application forms for the current
subscription year, which began in January, may be obtained from the Lantern Slides Service, Department of Pathology,
Massachusetts General Hospital, Boston, MA 02114 (telephone 617-726-2974) or e-mail Pathphotoslides@partners.org.
475